Acurx Pharmaceuticals Inc. (NASDAQ: ACXP)
$0.7672
+0.0087 ( -2.89% ) 46.6K
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
Market Data
Open
$0.7672
Previous close
$0.7585
Volume
46.6K
Market cap
$13.31M
Day range
$0.7730 - $0.8400
52 week range
$0.7200 - $5.2800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | May 15, 2024 |
| 10-q | Quarterly Reports | 52 | May 14, 2024 |
| ars | Annual reports | 1 | Apr 29, 2024 |
| def | Proxies and info statements | 4 | Apr 29, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 8-k | 8K-related | 15 | Mar 18, 2024 |
| 10-k | Annual reports | 77 | Mar 15, 2024 |
| 4 | Insider transactions | 1 | Jan 22, 2024 |